Comparison of serum iron, TIBC, transferrin saturation and serum ferritin in anemia of chronic renal diseases
DOI:
https://doi.org/10.18203/2320-6012.ijrms20190488Keywords:
Chronic kidney disease, Comparison, Control, Serum iron, Serum ferritinAbstract
Background: In patients with CKD and diabetes combined, anemia may be relative or absolute. If the serum ferritin is more than or equal to 100ng/ml associated with reduced iron saturation, then it is defined as functional iron deficiency anemia. This type of anemia is very common in patients with CKD. To compare serum iron, TIBC, transferrin saturation and serum ferritin in anemia of chronic renal diseases with healthy controls.
Methods: A hospital based comparative study was carried out among 30 known cases of chronic kidney disease with anemia. They were compared with 20 age and sex matched healthy control who were free from chronic kidney disease and anemia. The parameters like serum iron, TIBC, transferrin saturation and serum ferritin were compared between the two groups. Student’s t test and a two tailed p value were calculated and if the p value was less than 0.05, it was taken as statistically significant.
Results: It was seen that the mean hemoglobin value was significantly less among CKD patients compared to healthy controls (p<0.05). Serum iron was also significantly less among CKD patients compared to healthy controls (p<0.05). TIBC as significantly high among CKD patients compared to healthy controls (p<0.05). This is because of low hemoglobin and low serum iron in CKD patients but again the transferrin saturation was significantly low among CKD patients compared to healthy controls (p<0.05).
Conclusions: Anemia prevalence was very high in CKD patients. Hemoglobin, serum iron and transferrin saturation were significantly low and TIBC was significantly high.
References
Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the third national health and nutrition examination survey (1988-1994). Arch Inter Med. 2002;162(12):1401-8.
Joanne M, Bargman, Skorechi K. Disorders of the kidney and urinary tract. In: Harrison’s principle and practice of internal medicine. 17th ed. New York: Mc Graw-Hill; 2008:1761-1771.
Mehdi U, Toto RD. Anemia, diabetes, and chronic kidney disease. Diab Care. 2009;32(7):1320-6.
Erslev AJ. Anemia of chronic renal disease. Arch Inter Med. 1970;126(5):774-80.
Ruhräh J. Johannes lange 1485-1565: a note on the history of chlorosis. Am J Dis Child. 1934;48(2):393-6.
Eschbach JW, Mladenovic J, Garcia JF, Wahl PW, Adamson JW. The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo. J Clin Investigation. 1984;74(2):434-41.
Pinevich AJ, Petersen J. Erythropoietin therapy in patients with chronic renal failure. Western J Med. 1992;157(2):154.
Buttarello M, Pajola R, Novello E, Rebeschini M, Cantaro S, Oliosi F, et al. Diagnosis of iron deficiency in patients undergoing hemodialysis. Am J Clin Pathol. 2010;133(6):949-54.
Hussain A, Tayyeb M. Serum ferritin an indicator of bone marrow stores in hemolysed patients. Kidney Int. 1999:152-56.
Kaltwasser JP, Gottschalk R. Erythropoietin and Iron. Kidney Int. 1999;55(69):s49-s56.
Hsu CY, McCulloch CE, Curhan GC. Iron status and hemoglobin level in chronic renal insufficiency. J Am Soc Nephrol. 2002;13(11):2783-6.
Silverberg DS, Wexler D, Blum M, Tchebiner JZ, Sheps D, Keren G, et al. The effect of correction of anaemia in diabetics and non‐diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrology Dialysis Transplantation. 2003;18(1):141-6.
Kopyt NP. Chronic kidney disease: the new silent killer. J Am Osteopathic Assoc. 2006;106(3):133-6.
Buttarello M, Pajola R, Novello E, Rebeschini M, Cantaro S, Oliosi F, et al. Diagnosis of iron deficiency in patients undergoing hemodialysis. Am J Clin Pathol. 2010;133(6):949-54.
